Juárez-Figueroa LA, Uribe-Salas FJ, González-Rodríguez A, Iracheta-Hernández P, Ruiz-González V, Medina-Islas Y

Language: English
References: 26
Page: 147-153
PDF size: 230.94 Kb.

ABSTRACT

Objective. To describe results of HIV, sexually transmitted diseases (STI) and CD4 counts at the HIV-specialized Condesa Clinic (CC) in Mexico City. Materials and methods. Individuals who requested voluntary counseling and testing at CC were studied. We identified antibodies against HIV, syphilis, hepatitis C, and hepatitis B HBsAg. CD4 cell counts and viral load of HIV positive individuals were also obtained. Late HIV infection diagnosis was established if CD4 counts were lower than 200 cells/µL. Results. Global seroprevalence of HIV, syphilis, HBsAg, and anti HCV markers was of 20.1, 6, 1 and 1, respectively. Men displayed higher seroprevalence of infection markers than women. Among men, HIV infection was related to age and with all STI markers. Late HIV diagnosis was 31.8%. The risk of late HIV diagnosis was higher among women and it increased as age increased. Conclusions. Differences between genders regarding HIV and STIs prevalence as well as risk factors for HIV infection and late HIV diagnosis were observed.

REFERENCES

1. Instituto Nacional de Salud Pública. Informe técnico analítico sobre seroprevalencia de VIH y factores de riesgo y vulnerabilidad en hombres homosexuales y hombres bisexuales. Cuernavaca, México: Instituto Nacional de Salud Pública, 2012 [accessed on May 20, 2016]. Available in: http:// www.censida.salud.gob.mx/descargas/principal/Informe_Tecnico_Analitico_ HSH.pdf

2. Secretaría de Salud. Vigilancia Epidemiológica de casos de VIH/SIDA en México. Registro Nacional de Casos de SIDA Actualización al cierre de 2013. México: Secretaría de Salud, 2013 [accessed on May 20, 2016]. Available at: http://www.censida.salud.gob.mx/descargas/epidemiologia/ RN_CIERRE_2013.pdf

3. Bautista-Arredondo S, Colchero MA, Romero M, Conde-González CJ, Sosa-Rubí SG. Is the HIV epidemic stable among MSM in Mexico? HIV prevalence and risk behavior results from a nationally representative survey among men who have sex with men. PLoS One 2013; 8(9): e72616. http://dx.doi.org/10.1371/journal.pone.0072616

4. Eileen VP, Goodman-Meza D, Burgos JL, Abramovitz D, Chavarin CV, Torres K, et al. Prevalence and correlates of HIV among men who have sex with men in Tijuana, Mexico. J Int AIDS Soc 2015;18:19304. http://dx.doi. org/10.7448/IAS.18.1.19304

5. Galárraga O, Sosa-Rubí SG, González A, Badial-Hernández F, Conde- González CJ, Juárez-Figueroa L, et al. The disproportionate burden of HIV and STIs among male sex workers in Mexico City and the rationale for economic incentives. J Int AIDS Soc 2014;17(1):19218. http://dx.doi. org/10.7448/IAS.17.1.19218

6. Strathdee SA, Philbin MM, Semple SJ, Pu M, Orozovich P, Martínez G, et al. Correlates of injection drug use among female sex workers in two Mexico-US border cities. Drug Alcohol Depend 2008;92(1-3):132-140. http://dx.doi.org/10.1016/j.drugalcdep.2007.07.001

7. Strathdee SA, Lozada R, Sample SJ, Orozovich P, Pu M, Staines-Orozco H, et al. Characteristics of female sex workers with US clients in two border cities. Sex Transm Dis 2008;35(3):263-268. http://dx.doi.org/10.1097/ OLQ.0b013e31815b0

8. Ojeda VS, Strathdee SA, Lozada R, Rush ML, Fraga M, Orozovich P, et al. Association between migrant status and sexually transmitted infections among female sex workers in Tijuana. Sex Transm Infect 2009;85(6):420- 426. http://dx.doi.org/10.1136/sti.2008.032979

9. Patterson TL, Semple SJ, Staines H, Lozada R, Orozovich P, Bucardo J, et al. Prevalence and correlates of HIV infection among female sex workers in two Mexico US border cities. J Infect Dis 2008;197(5):728-732. https:// doi.org/10.1086/527379

10. Clínica Especializada Condesa [sitio de internet]. Ciudad de México [accessed June 17, 2016]. Available at: http://condesadf.mx/

11. Secretaría de Salud. Norma Oficial Mexicana NOM-010-SSA2-2010, Para la prevención y el control de la infección por Virus de la Inmunodeficiencia Humana [accessed on June 12, 2016]. Available at: http://www. censida.salud.gob.mx/descargas/drhumanos/NOM-010-SSA2-2010.pdf

12. Centers for Diseases Control and Prevention. 2015 Sexually Transmitted Diseases Guidelines. HIV infection: Detection, Counseling and Detection [accessed on June 12, 2016]. Available at: http://www.cdc.gov/ std/tg2015/hiv.htm

13. Juárez-Figueroa L, Iracheta P, Casillas J, González A. Toward “real time” HIV/STI diagnosis in the HIV/AIDS Program of Mexico City. XVIII International AIDS Conference; July 2010; Vienna, Austria.

14. Saavedra J, Izazola-Licea JA, Beirer Ch. Sex between men in the context of HIV: The AIDS 2008 Jonathan Mann Memorial Lecture in health and human rights. J Int AIDS Soc 2008;11:9. https://doi.org/10.1186/1758- 2652-11-9

15. UNAIDS. UNAIDS report on the global AIDS epidemic, 2012. Geneva, Switzerland: UNAIDS, 2012 [accessed on November 18, 2015]. Available at: http://www.unaids.org/en/resources/campaigns/20121120_globalreport2012/ globalreport/

16. Valdespino JL, García ML, Palacios M. El diagnóstico epidemiológico 1981-1995 y el primer Programa Nacional de Prevención: 1990-1994. In: Córdova JA, Ponce de León S, Valdespino JL, eds. 25 años de SIDA en México. Logros, desaciertos y retos. Cuernavaca, Mexico: INSP, 2009 [accessed on November 18, 2015]. Available at: http://www.censida.salud.gob. mx/descargas/SIDA25axos-26mar.pdf

17. Secretaría de Salud. El VIH/SIDA en México 2012. México: CENSIDA/ SS, 2012 [accessed on November 18, 2015]. Available at: http://www. censida.salud.gob.mx/descargas/biblioteca/VIHSIDA_MEX2012.pdf

18. Juárez-Figueroa LA, Uribe-Salas FJ, Conde-González CJ, Hernández- Ávila M, Hernández-Nevárez P, Uribe-Zúñiga P, et al. Hepatitis B markers in men seeking human immunodeficiency virus antibody testing in Mexico City. Sex Transm Dis 2007;24(4):211-217. https://doi. org/10.1097/00007435-199704000-00005

19. Chow EPF, Wilson DP, Zhang L. HIV and syphilis co-infection increasing among men who have sex with men in China: A systematic review and meta-analysis. PLoS One 2011;6(8):e22768. http://dx.doi.org/10.1371/ journal.pone.0022768

20. Deiss RG, Brouwer KC, Loza O, Lozada RM, Ramos M, Cruz MA, et al. High-risk sexual and drug using behaviors among male injection drug users who have sex with men in 2 Mexico-US border cities. Sex Transm Dis 2008;35(3):243-249. http://dx.doi.org/10.1097/OLQ.0b013e31815abab5

21. Gutiérrez JP, Sucilla-Pérez H, Conde-González CJ, Izazola JA, Romeromartínez M, Hernández-Ávila M. Seroprevalencia de VIH en población mexicana de entre 15 y 49 años: resultados de la Ensanut 2012. Salud Publica Mex 2014;56(4):323-332. http://dx.doi.org/10.21149/spm.v56i4.7352

22. Hernández-Girón C, Uribe-Salas F, Conde-González C, Cruz-Valdez A, Juárez-Figueroa L, Uribe-Zúñiga P, et al. Seroprevalencias a diversos virus y características sociodemográficas en mujeres que buscan detectarse VIH. Rev Invest Clin 1997;49(1):5-13.

23. Carrizosa CM, Blumberg EJ, Hovell MF, Martinez-Donate AP, García- González G, Lozada R, et al. Determinants and prevalence of late HIV testing in Tijuana, Mexico. AIDS Patient Care STDS 2010;24(5):333-340. http://dx.doi.org/10.1089/apc.2009.0138

24. Crabtree-Ramírez B, Caro-Vega Y, Velauzarán-Zamudio F, Sierra- Madero J. High prevalence of late diagnosis of HIV in Mexico during the HAART era. Salud Publica Mex 2012;54(5):506-514. http://dx.doi. org/10.1590/S0036-36342012000500007

25. García-Sánchez I. Gender differences in HIV. Gac Sanit 2004;18(suppl 2): 47-54. https://doi.org/10.1157/13061994

26. Tang HL, Mao YR, Zhang TJ, Han J, He N. Analysis of late diagnosis reasons of newly diagnosed HIV/AIDS patients. Zhonghua Yu Fang Yi Xue Za Zhi 2012;46(11):1004-1008.